Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Sirolimus

  • You have access
    Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature
    KRISTEN D. STARBUCK, RICHARD D. DRAKE, G. THOMAS BUDD and PETER G. ROSE
    Anticancer Research November 2016, 36 (11) 6161-6164;
  • You have access
    Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report
    BINDU V. MANYAM, TOBENNA I. NWIZU, MELISSA L. RAHE, BRIDGETT A. HARR and SHLOMO A. KOYFMAN
    Anticancer Research October 2015, 35 (10) 5511-5514;
  • You have access
    A Retrospective Study of Patients with Malignant PEComa Receiving Treatment with Sirolimus or Temsirolimus: The Royal Marsden Hospital Experience
    CHARLOTTE BENSON, JOANNA VITFELL-RASMUSSEN, MARCO MARUZZO, CYRIL FISHER, NINA TUNARIU, SCOTT MITCHELL, OMAR AL-MUDERIS, KHIN THWAY, JAMES LARKIN and IAN JUDSON
    Anticancer Research July 2014, 34 (7) 3663-3668;
  • You have access
    Differential Expression of p-mTOR in Cutaneous Basal and Squamous Cell Carcinomas Likely Explains their Different Response to mTOR Inhibitors in Organ-transplant Recipients
    GEORGIA KARAYANNOPOULOU, SYLVIE EUVRARD and JEAN KANITAKIS
    Anticancer Research September 2013, 33 (9) 3711-3714;
  • You have access
    Levels of Sirolimus in Saliva vs. Blood – the Rationale of Topical Oral Use for Oral Malignancy
    ZAKHAR NUDELMAN, NAAMA KESHET, MICHAL DRANITZKI ELHALAL, MICHAEL FRIEDMAN and RAKEFET CZERNINSKI
    Anticancer Research February 2013, 33 (2) 661-663;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire